消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）

2021-08-14 癌症支持疗法多国学会 Support Care Cancer.2021 Aug 14.

肠梗阻晚期癌症恶性结肠梗阻

恶性肠梗阻 (MBO) 是晚期癌症患者的常见并发症，尤其是结肠癌或妇科恶性肿瘤。 MASCC 先前于 2017 年发布了 MBO 症状管理指南。这是 5 年的更新。

中文标题：

2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）

英文标题：

Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update

发布机构：

癌症支持疗法多国学会

发布日期：

2021-08-14

简要介绍：

恶性肠梗阻 (MBO) 是晚期癌症患者的常见并发症，尤其是结肠癌或妇科恶性肿瘤。 MASCC 先前于 2017 年发布了 MBO 症状管理指南。这是 5 年的更新。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=88a341c00216554f, title=2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）, enTitle=Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update, guiderFrom=Support Care Cancer.2021 Aug 14., authorId=0, author=, summary=恶性肠梗阻 (MBO) 是晚期癌症患者的常见并发症，尤其是结肠癌或妇科恶性肿瘤。 MASCC 先前于 2017 年发布了 MBO 症状管理指南。这是 5 年的更新。, cover=https://img.medsci.cn/2021829/1630244252623_2020535.jpg, journalId=0, articlesId=null, associationId=993, associationName=癌症支持疗法多国学会, associationIntro=MASCC是癌症支持疗法多国学会的缩写，是一涉及癌症支持疗法的多学科的国际性组织。成员来自各大洲的60多个国家。MASCC成立于1990年，该组织致力于对各期癌症病人支持疗法各个方面的研究及教育。MASCC的工作目标是通过研究及科学认识的交流，提高支持疗法的专业水平。, copyright=0, guiderPublishedTime=Sat Aug 14 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="bp3-card bp3-elevation-0 result-block" style="color: #182026;"> <div class="bp3-collapse"> <div class="bp3-collapse-body bp3-fixed-positioning-containing-block" aria-hidden="false"> <div class="common-result"> <div class="general-result"> <p>恶性肠梗阻 (MBO) 是晚期癌症患者的常见并发症，尤其是结肠癌或妇科恶性肿瘤。 MASCC 先前于 2017 年发布了 MBO 症状管理指南。这是 5 年的更新。</p> </div> </div> </div> </div> </div>, tagList=[TagDto(tagId=1041, tagName=肠梗阻), TagDto(tagId=3325, tagName=晚期癌症), TagDto(tagId=49467, tagName=恶性结肠梗阻)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=49467, guiderKeyword=恶性结肠梗阻, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6598, appHits=239, showAppHits=0, pcHits=1009, showPcHits=6359, likes=0, shares=22, comments=5, approvalStatus=1, publishedTime=Sun Aug 29 22:36:14 CST 2021, publishedTimeString=2021-08-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 21:37:43 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 09:15:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）.pdf)])
2021 MASCC指南：晚期癌症患者恶性肠梗阻的内科管理（更新版）.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1076043, encodeId=46b610e6043a0, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Wed Dec 01 23:03:18 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073473, encodeId=0db810e3473e0, content=有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5NibzqOYLRdh69w8OIQmQ7a7tssgibydlnvN1ibcMDsOibOAqZE0ZQMSCiagwSCgFG2YGjibb5Phud41Q/132, createdBy=d2621692166, createdName=tracy117, createdTime=Wed Nov 24 10:39:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061869, encodeId=a71d10618694c, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:18:34 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055557, encodeId=65d0105555e89, content=想了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3391645692, createdName=阿亮, createdTime=Tue Sep 28 07:12:37 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-12-01 1e1a376dm19(暂无匿称)

    需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1076043, encodeId=46b610e6043a0, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Wed Dec 01 23:03:18 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073473, encodeId=0db810e3473e0, content=有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5NibzqOYLRdh69w8OIQmQ7a7tssgibydlnvN1ibcMDsOibOAqZE0ZQMSCiagwSCgFG2YGjibb5Phud41Q/132, createdBy=d2621692166, createdName=tracy117, createdTime=Wed Nov 24 10:39:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061869, encodeId=a71d10618694c, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:18:34 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055557, encodeId=65d0105555e89, content=想了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3391645692, createdName=阿亮, createdTime=Tue Sep 28 07:12:37 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-11-24 tracy117

    有用#肿瘤#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1076043, encodeId=46b610e6043a0, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Wed Dec 01 23:03:18 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073473, encodeId=0db810e3473e0, content=有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5NibzqOYLRdh69w8OIQmQ7a7tssgibydlnvN1ibcMDsOibOAqZE0ZQMSCiagwSCgFG2YGjibb5Phud41Q/132, createdBy=d2621692166, createdName=tracy117, createdTime=Wed Nov 24 10:39:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061869, encodeId=a71d10618694c, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:18:34 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055557, encodeId=65d0105555e89, content=想了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3391645692, createdName=阿亮, createdTime=Tue Sep 28 07:12:37 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-10-19 ms8000001549818402

    非常有用#肿瘤#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1076043, encodeId=46b610e6043a0, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6abb1990537, createdName=1e1a376dm19(暂无匿称), createdTime=Wed Dec 01 23:03:18 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073473, encodeId=0db810e3473e0, content=有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI5NibzqOYLRdh69w8OIQmQ7a7tssgibydlnvN1ibcMDsOibOAqZE0ZQMSCiagwSCgFG2YGjibb5Phud41Q/132, createdBy=d2621692166, createdName=tracy117, createdTime=Wed Nov 24 10:39:40 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061869, encodeId=a71d10618694c, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:18:34 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055557, encodeId=65d0105555e89, content=想了解一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3391645692, createdName=阿亮, createdTime=Tue Sep 28 07:12:37 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 阿亮

    想了解一下

    0

相关指南

2021 WSES意见书：既往无手术和已知疾病者肠梗阻的诊断和管理

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2021-07-03